Skip to main content

amlodipine besylate and olmesartan medoxomil

NDC 51407-859 · Golden State Medical Supply, Inc.

Generic nameamlodipine besylate and olmesartan medoxomil
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL
Strength5; 40 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
Marketing categoryNDA

Packages

51407-859-30 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51407-859-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51407-197 — olmesartan medoxomil, 51407-198 — olmesartan medoxomil, 51407-199 — olmesartan medoxomil, 51407-668 — amlodipine besylate valsartan hydrochlorothiazide, 51407-669 — amlodipine besylate valsartan hydrochlorothiazide, 51407-670 — amlodipine besylate valsartan hydrochlorothiazide, 51407-671 — amlodipine besylate valsartan hydrochlorothiazide, 51407-672 — amlodipine besylate valsartan hydrochlorothiazide, 51407-857 — amlodipine besylate and olmesartan medoxomil, 51407-858 — amlodipine besylate and olmesartan medoxomil, 51407-860 — amlodipine besylate and olmesartan medoxomil, 51407-950 — Amlodipine Besylate, 51407-951 — Amlodipine Besylate, 51655-044 — AMLODIPINE BESYLATE, 51655-201 — Amlodipine Besylate and Benazepril Hydrochloride, 51655-213 — Amlodipine and Benazepril Hydrochloride, 51655-291 — Amlodipine besylate, 51655-586 — Amlodipine besylate, 51655-869 — AMLODIPINE BESYLATE, 52605-041 — amlodipine besylate, +720 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels